These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12095048)

  • 1. Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune.
    Meier-Kriesche HU; Kaplan B
    Am J Transplant; 2002 Jan; 2(1):100-4. PubMed ID: 12095048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients.
    Goel M; Flechner SM; Ischikawa A; Induhara R; Mastroianni B; Savas K; Modlin C; Goldfarb D; Feng J; Cook DJ; Novick AC
    Clin Transplant; 2002 Dec; 16(6):442-9. PubMed ID: 12437625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
    Ulsh PJ; Yang HC; Holman MJ; Ahsan N
    J Transpl Coord; 1999 Jun; 9(2):114-8. PubMed ID: 10703393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
    Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
    Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased impact of acute rejection on chronic allograft failure in recent era.
    Meier-Kriesche HU; Ojo AO; Hanson JA; Cibrik DM; Punch JD; Leichtman AB; Kaplan B
    Transplantation; 2000 Oct; 70(7):1098-100. PubMed ID: 11045649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to Sandimmune.
    Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2001; 33(7-8):3422-3. PubMed ID: 11750465
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
    Malaise J; Saudek F; Boucek P; Adamec M; Van Ophem D; Squifflet JP;
    Transplant Proc; 2005; 37(6):2843-5. PubMed ID: 16182828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation.
    Jurewicz WA
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i7-11. PubMed ID: 12738757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
    Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M; Banasik M; Patrzałek D; Klinger M
    Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of maintenance immunosuppression medication on the change in kidney allograft function.
    Gill JS; Tonelli M; Mix CH; Johnson N; Pereira BJ
    Kidney Int; 2004 Feb; 65(2):692-9. PubMed ID: 14717943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus (FK506) versus cyclosporin A microemulsion (Neoral) maintenance immunosuppression: effects on graft survival and function, infection, and metabolic profile following kidney transplantation (KT).
    Abou-Jaoude MM; Ghantous I; Almawi WY
    Mol Immunol; 2003 Jul; 39(17-18):1095-100. PubMed ID: 12835083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion.
    Filler G; Trompeter R; Webb NJ; Watson AR; Milford DV; Tyden G; Grenda R; Janda J; Hughes D; Offner G; Klare B; Zacchello G; Brekke IB; McGraw M; Perner F; Ghio L; Balzar E; Friman S; Gusmano R; Stolpe J
    Transplant Proc; 2002 Aug; 34(5):1935-8. PubMed ID: 12176634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.